American Oncology Network, Inc. reported a 20.0% increase in revenue to $364.3 million for the first quarter of 2024, driven by a 7.1% growth in patient encounters and strategic acquisitions. The company's net loss before non-controlling interest was $24.9 million, and Adjusted EBITDA was $2.0 million.

American Oncology Network (AON) reported a revenue of $324.2 million for Q4 2023, a 7.9% increase compared to Q4 2022. The increase was primarily driven by a 9.5% growth in patient encounters. However, the company experienced a net loss of $22.4 million, compared to a net income of $1.4 million in the same quarter of the previous year, mainly due to incremental accounts receivable reserves.